Safety and Efficacy of a New High-Dose Chemotherapy (HDC) Regimen of Panobinostat (Pano), Gemcitabine (Gem), Busulfan (Bu) and Melphalan (Mel) (Pano/GBM) with Autologous Stem Cell Transplant (ASCT) for Patients (pts) with High-Risk (HR) or Refractory/Relapsed (R/R) Myeloma (MM) – Matched Pair Comparisons with a Concurrent Control Cohort

Autor:	Yago Nieto, Zixi Yang, Ben C. Valdez, Suprateek Kundu, Roland Bassett, Melissa Barnett, Qaiser Bashir, Jeremy Ramdial, Neeraj Y. Saini, Samer A. Srour, Jin Seon Im, Partow Kebriaei, Uday R. Popat, Alison M. Gulbis, Rita Cool, Terri Lynn Shigle, Whitney Dale Wallis, Jason Yeh, Ruby Delgado, Sofia Qureshi, Hans C. Lee, Elisabet Manasanch, Robert Z. Orlowski, Sheeba K. Thomas, Elizabeth J. Shpall, Borje S. Andersson, Muzaffar H. Qazilbash
Rok vydání:	2023
Předmět:	Transplantation Molecular Medicine Immunology and Allergy Cell Biology Hematology
Zdroj:	Transplantation and Cellular Therapy. 29:S31-S32
ISSN:	2666-6367
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::80858ea262e69e657d061b4d73be9af6 https://doi.org/10.1016/s2666-6367(23)00107-0 Zobrazit plný text záznamu Full Text from ScienceDirect